Treatment Use of ECMO In Pregnancy or Peripartum Patient.

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04144660

Enrollment

Registered

2019-10-30

Start date

2019-10-28

Completion date

2020-03-31

Last updated

2020-11-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiogenic Shock, Complication, Pregnancy, Peripartum Cardiomyopathy

Brief summary

The goal of this study is to describe the use of ECMO (Extracorporeal Membrane Oxygenation) in the pregnant or peripartum patient.

Interventions

DEVICEExtracorporeal Membrane Oxygenation

Use of ECMO for circulatory / hemodynamic support of peripartum of pregnant patients who developed cardiogenic shock.

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

1. Female 2. Age 18 years or greater at the time of ECMO treatment. 3. Pregnant or within 6 months post-partum at the time of ECMO cannulation

Exclusion criteria

1. No history of pregnancy. 2. No treatment with ECMO.

Design outcomes

Primary

Measure	Time frame	Description
Clinical Outcome of Mother	Time of diagnosis -Six Month Survival Rate	Describe clinical course of pregnant or recently postpartum patients with cardiogenic shock treated with ECMO, including the rate of neonate survival

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026